Voce Capital Management’s Evolent Health EVH Stock Holding History

Voce Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$9.81M	Sell	323,694 -34,357	-10%	-$1.11M	16.97%	3
2023 Q1	$11.6M	Sell	358,051 -43,871	-11%	-$1.39M	17.38%	2
2022 Q4	$11.3M	Buy	401,922 +141,459	+54%	+$4.06M	6.49%	3
2022 Q3	$9.36M	Sell	260,463 -36,236	-12%	-$1.28M	6.08%	3
2022 Q2	$9.11M	Sell	296,699 -79,416	-21%	-$2.31M	4.56%	3
2022 Q1	$12.1M	Buy	376,115 +31,684	+9%	+$830K	4.8%	3
2021 Q4	$9.53M	Hold	344,431	–	–	3.39%	3
2021 Q3	$10.7M	Sell	344,431 -51,083	-13%	-$1.23M	3.87%	4
2021 Q2	$8.35M	Buy	395,514 +115,114	+41%	+$2.31M	3%	4
2021 Q1	$5.66M	Sell	280,400 -70,649	-20%	-$1.34M	2.54%	4
2020 Q4	$5.63M	Sell	351,049 -404,486	-54%	-$5.35M	2.9%	4
2020 Q3	$9.38M	Buy	755,535 +593,329	+366%	+$6.98M	5.96%	4
2020 Q2	$1.16M	Hold	162,206	–	–	0.8%	10
2020 Q1	$881K	Buy	162,206 +5,637	+4%	+$50.4K	0.67%	12
2019 Q4	$1.42M	Sell	156,569 -543,919	-78%	-$4.42M	0.83%	9
2019 Q3	$5.04M	Buy	700,488 +270,996	+63%	+$1.94M	2.7%	5
2019 Q2	$3.41M	Buy	+429,492	New	+$5.09M	1.78%	8

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Voce Capital Management's EVH Position: Q2 2023 in Review

Voce Capital Management reduced its Evolent Health (EVH) stake by 9.6% in Q2 2023, selling an estimated $1.11M and leaving 323,694 shares worth $9.81M. The position accounts for 16.97% of the portfolio, ranked #3.

Voce Capital Management first reported a position in EVH in Q2 2019 and has held it in 17 quarters since. The position peaked at $12.1M in Q1 2022. 217 funds tracked by Wall St. Rank hold EVH as of Q2 2023.

Voce Capital Management held 323,694 shares of Evolent Health worth $9.81M as of Q2 2023.
Voce Capital Management sold 34,357 Evolent Health shares in Q2 2023, an estimated $1.11M.
Evolent Health made up 16.97% of Voce Capital Management's portfolio in Q2 2023, its #3 holding.
Voce Capital Management first reported a position in Evolent Health in Q2 2019 and has held it in 17 quarters since.
Voce Capital Management's Evolent Health position peaked at $12.1M in Q1 2022.
217 funds tracked by Wall St. Rank held Evolent Health as of Q2 2023.

Based on Voce Capital Management's 13F filing for Q2 2023, filed 31 Jul 2023.